NCT00649311 - A Study To Evaluate The Efficacy Of Eplerenone Compared With Losartan For The Treatment Of Patients With Mild To Moderate Hypertension | Biotech Hunter

Enrollment

248

Participants

Timeline

Start Date

April 30, 2003

Study Completion Date

September 30, 2003

Conditions

Hypertension

Interventions

DRUG

eplerenone

Eplerenone 50 mg oral film-coated tablet once daily for 8 weeks. If blood pressure was uncontrolled (DBP ≥ 90 mmHg) at Week 4, the dose was increased to eplerenone 100 mg oral film-coated tablet once daily for 4 weeks.

DRUG

Losartan

Losartan 50 mg oral capsule once daily for 8 weeks. If blood pressure was uncontrolled (DBP ≥ 90 mmHg) at Week 4, the dose was increased to losartan 100 mg oral capsule once daily for 4 weeks

Trial Locations (2)

Unknown

Pfizer Investigational Site, Kaohsiung City

Pfizer Investigational Site, Taipei